Noncytotoxic Pyrrolobenzodiazepine–Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis

[Image: see text] The development of new antitubercular agents for the treatment of infections caused by multidrug-resistant (MDR) Mycobacterium tuberculosis is an urgent priority. Pyrrolobenzodiazepines (PBDs) are a promising class of antibacterial agents that were initially discovered and isolated...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:ACS Omega
Päätekijät: Picconi, Pietro, Jeeves, Rose, Moon, Christopher William, Jamshidi, Shirin, Nahar, Kazi S., Laws, Mark, Bacon, Joanna, Rahman, Khondaker Miraz
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Chemical Society 2019
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6921268/
https://ncbi.nlm.nih.gov/pubmed/31867477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b00834
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia